🇺🇸 FDA
Pipeline program

Autologous Engineered Urethral Construct

IRB00043624

Phase 1 mab active

Quick answer

Autologous Engineered Urethral Construct for Urologic Diseases is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Urologic Diseases
Phase
Phase 1
Modality
mab
Status
active

Clinical trials